Search
for
Sort by
Research 121–150 of 1000+
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- New Treatment Options for Alopecia Areata
- Baricitinib Attenuates IFN-γ and Polyinosinic:polycytidylic Acid‒Induced Mitochondrial Damage and Inflammasome Activation in Human Keratinocytes
- Selective blockade of γc pathway ameliorates alopecia areata in a humanized murine model
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Upadacitinib in the treatment of a patient with the triad of atopic dermatitis, vitiligo, and alopecia areata: a case report and literature review
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Efficacy of Tofacitinib in the Treatment of Universal Alopecia Areata and Primary Sjögren Syndrome
- Combination Therapy with Baricitinib and Narrowband Ultraviolet B for Active Non-Segmental Vitiligo: A Retrospective Controlled Study
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Baricitinib as a treatment for myasthenia gravis: A case report
- Palmoplantar pustulosis–like eruption following tofacitinib therapy for juvenile idiopathic arthritis
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- The use of topical ruxolitinib 1.5% cream in frontal fibrosing alopecia: A case report
- Deucravacitinib in dermatology: current indication and existing off-label data
- Significant improvement with ivarmacitinib after suboptimal response to tofacitinib in severe alopecia areata: a case report and literature review
- Possible Involvement of Skin‐Resident Memory T Cells in Refractory Chronic Alopecia Areata
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Multiomics Analysis of the Response to Ritlecitinib in Alopecia Areata Subtypes and Correlation With Efficacy
- Citrullination at the Inflammatory Skin Barrier
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Complete Regrowth of Beard Hair with Ruxolitinib in an Alopecia Universalis Patient
- Successful treatment of severe atopic dermatitis and alopecia universalis with upadacitinib in a 29-year-old male patient
- Image 4_Associations between ionomic profile and metabolic abnormalities in a murine model of sodium sulfide induced alopecia areata.tif